Hi

Hi! How can I help you today?

Tell me details about oc pills and it's action and contradiction

Reading File
Finding Sources
Finding Sources
Searching PubMed

"oral contraceptives" AND "mechanism" AND "contraindications"

Reading File
Reading File
Finding Sources
Reading File
Reading File
Here is a detailed overview of oral contraceptive (OC) pills based on authoritative medical textbooks:

Oral Contraceptive (OC) Pills

Types

1. Combined Oral Contraceptive Pills (COCPs)
  • Contain ethinyl estradiol (estrogen component) + a progestin
  • Progestins come in 4 generations, each with different androgenic profiles and side effects
  • Lower-dose modern pills have fewer metabolic side effects than older high-dose formulations
2. Progestin-Only Pills (Mini-Pills)
  • Contain only a progestin (e.g., norethindrone)
  • Used when estrogen is contraindicated (e.g., breastfeeding, smoking over 35)

Mechanism of Action

COCPs work through three main mechanisms:
MechanismDetails
Ovulation suppressionExogenous hormones suppress the hypothalamic-pituitary-ovarian (HPO) axis, inhibiting LH/FSH surges and preventing follicular maturation
Cervical mucus thickeningProgestin cross-links cervical mucus, making it impenetrable to sperm - especially important in low-dose pills
Endometrial alterationAlters endometrial receptivity to the fertilized ovum, making implantation unlikely
Progestin-only pills rely more on thickening cervical mucus and have weaker ovulation suppression.

Non-Contraceptive Benefits

  • Reduced dysmenorrhea and ovulatory pain (mittelschmerz)
  • Improvement of acne vulgaris and hirsutism (especially with anti-androgenic progestins)
  • Regulation of menstrual cycles
  • Reduced iron-deficiency anemia (lighter periods)
  • Decreased risk of ovarian and endometrial cancers (50% reduction in endometrial cancer; effect persists 15 years after stopping)
  • Decreased risk of colorectal cancer
  • Reduced incidence of pelvic inflammatory disease (PID)

Adverse Effects

Estrogen excess:
  • Nausea, breast tenderness
  • Edema, headache
  • Increased clotting factors (thromboembolic risk)
  • Hypertension
Progestin excess:
  • Depression, decreased libido, fatigue
  • Weight gain
  • Decreased HDL, increased LDL
  • Decreased glucose tolerance (diabetogenic)
Androgenic effects (19-norprogestins):
  • Acne, hirsutism, oily skin
  • Cholestatic jaundice (rare)
Breakthrough bleeding (BTB):
  • Most commonly due to non-compliance
  • Usually resolves within the first 3 cycles

Serious Complications

  • Thromboembolic events (DVT, PE) - related to estrogen component
  • Arterial thrombosis - stroke, myocardial infarction (especially in smokers and migraineurs with aura)
  • Hypertension
  • Hepatic adenoma (rare)
The ethinyl estradiol causes dose-dependent increases in pro-coagulant serum factors. In healthy non-smokers, compensatory fibrinolytic activity offsets this, but smokers lose this protective effect.

Contraindications

Absolute Contraindications

Condition
Acute mononucleosis
History of cerebrovascular accident (stroke)
Coronary artery disease
Known/suspected breast carcinoma
Estrogen-dependent neoplasia
Malignant or benign liver neoplasm
Thrombophlebitis or thromboembolic disorder (including Factor V Leiden carriers)
Known or suspected pregnancy
Classic migraines (with aura)
Women age ≥35 who smoke

Relative Contraindications

Condition
Term pregnancy within the previous 3 weeks
Hypertension ≥140/90 mmHg on three visits
Diastolic BP >110 mmHg on one visit
Impaired liver function
Breastfeeding (lactation)
Major surgery or lower limb immobilization planned within 4 weeks
Previous cholestasis of pregnancy
Undiagnosed abnormal vaginal bleeding
Note: Common migraines without aura and obesity are not absolute contraindications to COC use.

Initiating OC Pills

  • Quick-start method: Begin on the day of the office visit - associated with higher adherence at 3 months and no higher risk of irregular bleeding
  • Traditional Sunday start or first-day-of-period start: Still widely used
  • If adverse effects persist beyond 3 months, they are considered valid and a pill switch is warranted

Progestin-Only Pill Specifics

  • Preferred for breastfeeding mothers (does not reduce lactation unlike estrogen-containing pills)
  • No increased risk of thromboembolic events
  • Main side effect: irregular, unpredictable spotting/breakthrough bleeding - the primary reason for discontinuation

Sources: Swanson's Family Medicine Review, 8th ed. | Textbook of Family Medicine, 9th ed. | Goodman & Gilman's Pharmacological Basis of Therapeutics
This is a shared conversation. Sign in to Orris to start your own chat.